B.Riley cuts Burford Capital stock price target to $7.50 on YPF case

B. Riley cut Burford Capital's price target to $7.50 from $18.00 while keeping a Buy, assigning YPF-related assets a $0 value after a Second Circuit decision and raising its discount rate to 10%. Burford trades at $4.14, down 47% over the past week and 54% YTD, with InvestingPro flagging rapid cash burn. Insiders bought over $4.3M of stock (CEO ~228,264 shares; CIO ~229,794 shares; CFO and CDO bought via deferred comp at $8.27/share). Wedbush and BofA initiated coverage with price targets of $14.00 and $14.55, respectively.

Analysis

Burford’s equity is behaving like a binary option on a handful of large litigations rather than a diversified asset manager; a single adverse ruling shifts NPV assumptions, forces a higher discount rate and accelerates cash burn dynamics. That means small changes in case probability (e.g., 10–30ppt swing) can move implied equity value by multiples, so trading should be catalyst-driven and volatility-aware rather than buy-and-hold.

Insider purchases and fresh buy-side coverage create a narrative overlap: visible confidence versus liquidity reality. Structurally, insider participation that flows through deferred-compensation plans reduces immediate sell-side pressure but does not extend corporate runway; interpret insider buying as partial signal of perceived mispricing, not as underwriting of future capital needs.

The largest operational risk is funding/dilution: if litigation outcomes remain uncertain over the next 6–18 months, management will face either distress-priced equity raises or asset sales, both of which compress recovery to current shareholders. Conversely, the tail-recovery case (partial settlement or favorable appellate reversal) is a high-payoff, relatively short-dated catalyst—meaning asymmetric option strategies and event-driven hedges dominate simple directional exposure.

Key Decisions for Investors

• Directional-with-hedge (preferred): Long BUR equity sized for 2–4% portfolio exposure + buy 12-month puts ~35–45% downside protection. Timeframe: 6–12 months. R/R: preserves upside (target 100–200% on positive legal development) while capping catastrophic dilution-driven loss to ~35%.
• Volatility/catalyst trade: Buy BUR 3–6 month long calls (or a call debit spread to control premium) ahead of key filings/appeals and sell shorter-dated calls after IV compression. Timeframe: 1–6 months. R/R: asymmetric payoff if a court event reintroduces monetization prospects; limit premium at 2–4% of position value.
• Contrarian tail-bet: Purchase deep OTM LEAP calls (~12–24 month) at small notional (0.5–1% portfolio) to capture low-probability, high-payoff reversal of current case valuation. Timeframe: 12–24 months. R/R: low cost for >3x upside if asset value is reinstated or an unexpected settlement occurs.
• Liquidity risk mitigation: Avoid unhedged large longs into any announced capital raise windows; if management announces equity issuance, trim to zero and redeploy into short-dated option structures to retain upside exposure with limited drawdown. Timeframe: immediate upon raise announcement. R/R: preserves optionality while avoiding dilution shock.